Cargando…

Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer’s disease patients

BACKGROUND: Despite numerous clinical trials and decades of endeavour, there is still no effective cure for Alzheimer's disease. Computational drug repositioning approaches may be employed for the development of new treatment strategies for Alzheimer’s patients since an extensive amount of omic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bayraktar, Abdulahad, Li, Xiangyu, Kim, Woonghee, Zhang, Cheng, Turkez, Hasan, Shoaie, Saeed, Mardinoglu, Adil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199278/ https://www.ncbi.nlm.nih.gov/pubmed/37210557 http://dx.doi.org/10.1186/s12967-023-04192-6

Ejemplares similares

A Gene Co-Expression Network-Based Drug Repositioning Approach Identifies Candidates for Treatment of Hepatocellular Carcinoma
por: Yuan, Meng, et al.
Publicado: (2022)

Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach
por: Li, Xiangyu, et al.
Publicado: (2022)

Revealing the Molecular Mechanisms of Alzheimer’s Disease Based on Network Analysis
por: Bayraktar, Abdulahad, et al.
Publicado: (2021)

Stratification of patients with clear cell renal cell carcinoma to facilitate drug repositioning
por: Li, Xiangyu, et al.
Publicado: (2021)

Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning
por: Zhang, Cheng, et al.
Publicado: (2022)

Applications of Genome-Wide Screening and Systems Biology Approaches in Drug Repositioning
por: Mohammadi, Elyas, et al.
Publicado: (2020)

Current Status of COVID-19 Therapies and Drug Repositioning Applications
por: Altay, Ozlem, et al.
Publicado: (2020)

Histidyl-Proline Diketopiperazine Isomers as Multipotent Anti-Alzheimer Drug Candidates
por: Turkez, Hasan, et al.
Publicado: (2020)

Multi-omics approaches for revealing the complexity of cardiovascular disease
por: Doran, Stephen, et al.
Publicado: (2021)

Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning
por: Turanli, Beste, et al.
Publicado: (2019)

Systems Biology Approaches to Decipher the Underlying Molecular Mechanisms of Glioblastoma Multiforme
por: Kaynar, Ali, et al.
Publicado: (2021)

Open MoA: revealing the mechanism of action (MoA) based on network topology and hierarchy
por: Liao, Xinmeng, et al.
Publicado: (2023)

Drug Repositioning for Effective Prostate Cancer Treatment
por: Turanli, Beste, et al.
Publicado: (2018)

Repositioning of Anti-Inflammatory Drugs for the Treatment of Cervical Cancer Sub-Types
por: Kori, Medi, et al.
Publicado: (2022)

Drug repositioning in epilepsy reveals novel antiseizure candidates
por: Brueggeman, Leo, et al.
Publicado: (2018)

Targeted Gene Candidates for Treatment and Early Diagnosis of Age-Related Macular Degeneration
por: Cinici, Emine, et al.
Publicado: (2021)

Characterization of an in vitro steatosis model simulating activated de novo lipogenesis in MAFLD patients
por: Kim, Woonghee, et al.
Publicado: (2023)

Boron Nitride Nanoparticles Loaded with a Boron-Based Hybrid as a Promising Drug Carrier System for Alzheimer’s Disease Treatment
por: Yıldırım, Özge Çağlar, et al.
Publicado: (2022)

Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer
por: Beklen, Hande, et al.
Publicado: (2020)

Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19
por: Altay, Ozlem, et al.
Publicado: (2021)

Alzheimer’s disease master regulators analysis: search for potential molecular targets and drug repositioning candidates
por: Vargas, D. M., et al.
Publicado: (2018)

Integrative Network-Based Analysis Reveals Gene Networks and Novel Drug Repositioning Candidates for Alzheimer Disease
por: Gerring, Zachary F., et al.
Publicado: (2021)

Systems Analysis Reveals Ageing-Related Perturbations in Retinoids and Sex Hormones in Alzheimer’s and Parkinson’s Diseases
por: Lam, Simon, et al.
Publicado: (2021)

Revealing the Metabolic Alterations during Biofilm Development of Burkholderia cenocepacia Based on Genome-Scale Metabolic Modeling
por: Altay, Ozlem, et al.
Publicado: (2021)

Genome-Scale Metabolic Modeling of Glioblastoma Reveals Promising Targets for Drug Development
por: Larsson, Ida, et al.
Publicado: (2020)

Classification of clear cell renal cell carcinoma based on PKM alternative splicing
por: Li, Xiangyu, et al.
Publicado: (2020)

Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis
por: Zeybel, Mujdat, et al.
Publicado: (2022)

Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
por: Parisi, Daniele, et al.
Publicado: (2020)

Integrated transcriptomics reveals master regulators of lung adenocarcinoma and novel repositioning of drug candidates
por: De Bastiani, Marco Antônio, et al.
Publicado: (2019)

A network-based approach reveals the dysregulated transcriptional regulation in non-alcoholic fatty liver disease
por: Yang, Hong, et al.
Publicado: (2021)

Screening of Drug Repositioning Candidates for Castration Resistant Prostate Cancer
por: Kim, In-Wha, et al.
Publicado: (2019)

Assessment of the neuroprotective potential of d-cycloserine and l-serine in aluminum chloride-induced experimental models of Alzheimer’s disease: In vivo and in vitro studies
por: Tozlu, Özlem Özdemir, et al.
Publicado: (2022)

The in vitro cytotoxic, genotoxic, and oxidative damage potentials of the oral artificial sweetener aspartame on cultured human blood cells
por: ÇADIRCI, Kenan, et al.
Publicado: (2020)

The Pharmacorank Search Tool for the Retrieval of Prioritized Protein Drug Targets and Drug Repositioning Candidates According to Selected Diseases
por: Gnilopyat, Sergey, et al.
Publicado: (2022)

Niacin as a drug repositioning candidate for hyperphosphatemia management in dialysis patients
por: Shin, Sooyoung, et al.
Publicado: (2014)

Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer’s Disease
por: Corbett, Anne, et al.
Publicado: (2013)

β-Secretase-1: In Silico Drug Reposition for Alzheimer’s Disease
por: Galeana-Ascencio, Roberto A., et al.
Publicado: (2023)

Ellagic Acid and Its Metabolites as Potent and Selective Allosteric Inhibitors of Liver Pyruvate Kinase
por: Battisti, Umberto Maria, et al.
Publicado: (2023)

iDrug: Integration of drug repositioning and drug-target prediction via cross-network embedding
por: Chen, Huiyuan, et al.
Publicado: (2020)

Predicting associations among drugs, targets and diseases by tensor decomposition for drug repositioning
por: Wang, Ran, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2smmi0se3ar0v2fr575rqbacka